The Cardiovascular Division is extremely proud of the more than 300 cardiology fellows, graduate students (PhD and MD/PhD) and post-doctoral research fellows that have received their cardiovascular training at Washington University School of Medicine.
Former faculty and trainees of the Cardiovascular Division have gone on to become the president of Ecuador, chancellors and deans of medical schools, chairs of medicine, chiefs of cardiology, and leaders in the pharmaceutical industry.
The Alumni Section of the Cardiovascular Division website is dedicated to our former faculty and trainees. This section of the website will feature a “Message from the Chief,” which will be updated bi-annually, and will contain a brief summary of current events within the Cardiovascular Division. The Alumni Section will also post the most recent bi-annual update of the Cardiovascular Division alumni newsletter, which is also available as a downloadable pdf file.
Our goal is to remain connected with our former faculty and trainees, who have contributed to the rich clinical, teaching and research environment that exists in the Cardiovascular Division today.
Message from the Chief
These are not ordinary times, and what I have seen most visibly these past few months as we have faced a worldwide pandemic has been dedicated faculty and staff doing extraordinary work.
From research into what causes some of the devastating cardiovascular complications in COVID-19 patients to unwavering efforts to maintain and enhance premier patient care, our Division has risen to the challenge of meeting healthcare needs in a rapidly changing environment.
We have exceptional expertise in flexibility and innovation, which has enabled us to weather the move of our cardiovascular intensive care unit multiple times as the number of critically ill COVID-19 patients ebbs and wanes. We’ve also rapidly adapted to tele-health practices, something I see as an integral part of our services going forward.
Together with many of you, we are sharing best practices and challenges and delving into the mechanisms that make COVID-19 so lethal to many. Already we see promising treatment options. No one could have ever predicted a pandemic of this nature, but I’m proud to see our Division respond in so many innovative ways.
Gregory A. Ewald, MD, FACC
Interim Chief, Cardiovascular Division